This is a preview of subscription content, log in via an institution to check access.
Notes
see Reactions 1508 p3; 803105363
Reference
European Medicines Agency. PRAC recommends measures to reduce risk of heart problems with Corlentor/Procoralan (ivabradine): PRAC recommendations to be considered by CHMP for final opinion. Internet Document : [2 pages], 7 Nov 2014. Available from: URL: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2014/11/WC500177104.pdf
Rights and permissions
About this article
Cite this article
EMA aims to reduce heart problems with ivabradine. Reactions Weekly 1528, 2 (2014). https://doi.org/10.1007/s40278-014-5009-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-5009-x